Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Mid-range Performer
251.9500 -5.90 (-2.29%)
NSE Jun 06, 2025 15:46 PM
Volume: 1.2M
 

251.95
-2.29%
Karvy
Marksans Pharma has acquired US based Time-Cap Labs Inc in a transaction was valued at USD 28 mn. Time-Cap Laboratories, Inc is a New York based solid dosage tablet manufacturer synergies arise as it seeks to grow its presence in USA leveraging the manufacturing and packaging facilities of Time-cap, the brand equity of its products and distribution value chain. Time-cap has revenues of USD 30 mn per year and EBITDA of USD 4 mn and is a debt free company
Marksans Pharma Ltd. has gained 70.41% in the last 1 Year
More from Marksans Pharma Ltd.
Recommended